Updates

Author Details

Joe Pierce

September 23, 2020September 23, 2020
Sumifilam Lowers Levels of Multiple Biomarkers of Disease Activity, Trial Shows

Treatment with sumifilam significantly lowered the levels of multiple biomarkers of disease activity, neurodegeneration, and inflammation in people with mild-to-moderate Alzheimer’s after 28 days ... Read more
September 21, 2020September 17, 2020
Preventing Bias Against People With Alzheimer’s Disease

Ageism is brutal, especially when combined with a misunderstanding of dementia. Somehow, rude people forget that they will one day get old. If we’re ... Read more
September 21, 2020September 21, 2020
Specific Tau Protein Shows Potential as Blood Biomarker in Early Studies

A specific form of the tau protein, called phosphorylated-tau-217 or p-tau217, may function as a blood biomarker of Alzheimer’s disease, allow the development of blood tests ... Read more
September 16, 2020September 16, 2020
Theme for World Alzheimer’s Month Is ‘Let’s Talk About Dementia’

Events are underway to mark World Alzheimer’s Month, observed every September to raise global awareness about the disease and challenge the stigma regarding dementia. ... Read more
September 14, 2020September 10, 2020
The Dirty Secret Behind Caregiving

Do you know the dirty little secret of caregiving? Here it is: No one loves it. None of us like to admit how much ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Author Details

Joe Pierce

Thanks! Please check your email for a confirmation email.

November 8, 2017November 8, 2017

Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment

News

Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more

Sumifilam Lowers Levels of Multiple Biomarkers of Disease Activity, Trial Shows

Preventing Bias Against People With Alzheimer’s Disease

Specific Tau Protein Shows Potential as Blood Biomarker in Early Studies

Theme for World Alzheimer’s Month Is ‘Let’s Talk About Dementia’

The Dirty Secret Behind Caregiving

Phase 3 Trial of AXS-05 to Treat Agitation in Alzheimer’s Likely by Year’s End

First Patients Dosed in Annovis Bio’s ANVS401 Trial, Delayed Due to COVID-19

Part the Cloud Awards $24M to Researchers Studying Potential Alzheimer’s Treatments

Alzheimer’s Care During a Catastrophic Event

Technique That Opens Blood-Brain Barrier May Help Target Treatment, Study Says

Patients in Australian Trials of Anavex 2-73 May Continue Using Therapy, Agency Says

Subscribe to our mailing list

Caregivers Face Increased Health Risks Compared With Noncaregivers

GAIN Trial Reaches Milestone With 500 Patients Enrolled

AFA Awards $518K for Study of Neuroimmune Interactions in AD Onset, Progression

How to Support a Friend With Alzheimer’s and Their Family

AC Immune Moves Closer to Clinical Studies of Anti-TDP-43 Antibody

XPro1595 Lowers Neuroinflammation in Mild to Moderate Alzheimer’s, Interim Results Show

Young People May Exhibit Risks Associated With Alzheimer’s Disease, Research Finds

Aducanumab Wins FDA Priority Review, Moves Closer to US Approval

Rare Disease Communities Invited to Submit Works to 2020 Rare Artist Contest

Why an Aging Population Might Not Exercise

Trial of Potential Alzheimer’s Vaccine Advances to Medium Dose Group

People With Alzheimer’s Disease Often Resist Loss of Control

Flu, Pneumonia Vaccinations Linked to Reduced Risk of Alzheimer’s, Researchers Say

FDA to Consider Nuplazid to Treat Dementia-related Psychosis

Care Facilities Lockdown Is Hard on Parents with Dementia

Global Phase 3 Trial Will Test BAN2401 in Early-stage Asymptomatic Alzheimer’s

Alzheimer’s Foundation Expands Toll-free Helpline to Support Patients, Caregivers

Will Alzheimer’s Disease Affect Voter Turnout by Seniors?

Biogen, Eisai Seek FDA Approval of Aducanumab for Alzheimer’s

Foundation Offers Free Online Memory Screenings

Caregiving Is a Judgment-free Zone

AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

Simple Solutions to Everyday Caregiving Challenges

Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy

Advanced Imaging Captures Protein Clumps in Neurons at Early Alzheimer Stages

Father’s Day Prompts Memories of My Mom’s Dementia Diagnosis

Amyloid Clumps Formed on Space Station Affected by Microgravity

Anavex 2-73 Trial for Early Alzheimer’s Expanded to Canada, UK

Let’s Use Alzheimer’s and Brain Awareness Month to Eliminate Brain Freeze

Neurotrope Launches Long-term Trial of Bryostatin-1

Pin It on Pinterest